| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MYOG |
| Uniprot No | P15173 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-224aa |
| 氨基酸序列 | MELYETSPYFYQEPRFYDGENYLPVHLQGFEPPGYERTELTLSPEAPGPL EDKGLGTPEHCPGQCLPWACKVCKRKSVSVDRRRAATLREKRRLKKVNEA FEALKRSTLLNPNQRLPKVEILRSAIQYIERLQALLSSLNQEERDLRYRG GGGPQPGVPSECSSHSASCSPEWGSALEFSANPGDHLLTADPTDAHNLHS LTSIVDSITVEDVSVAFPDETMPN |
| 预测分子量 | 51 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于MYOG(肌生成素)重组蛋白的3篇参考文献及其摘要概括：
1. **标题**: "Expression and purification of functional recombinant myogenin in insect cells"
**作者**: Thompson PD, et al.
**摘要**: 该研究利用杆状病毒表达系统在昆虫细胞中高效生产重组肌生成素，并通过体外实验证实其能够激活肌肉特异性启动子，证实了重组蛋白的转录活性。
2. **标题**: "Myogenin recombinant protein enhances muscle regeneration in a murine injury model"
**作者**: Chen L, et al.
**摘要**: 通过在小鼠肌肉损伤模型中注射重组MYOG蛋白，研究发现其显著促进卫星细胞活化和肌纤维再生，表明其在肌肉修复治疗中的潜在应用价值。
3. **标题**: "Crystal structure of recombinant human myogenin reveals DNA-binding mechanism"
**作者**: Gupta R, et al.
**摘要**: 解析了重组人源肌生成素的晶体结构，揭示了其碱性螺旋-环-螺旋(bHLH)结构域与DNA靶序列结合的分子机制，为理解肌肉分化的分子基础提供结构依据。
(注：上述文献为示例，实际引用时建议通过数据库验证具体信息。)
Myogenin (MYOG), a key regulator of skeletal muscle development, belongs to the myogenic regulatory factor (MRF) family, which includes MyoD, Myf5. Myogenin, and MRF4. Discovered in the late 1980s, MYOG is essential for myoblast differentiation into mature multinucleated muscle fibers. It functions by binding to E-box DNA sequences in promoter regions of muscle-specific genes, activating their transcription. MYOG expression peaks during mid-to-late myogenesis, coordinating cell cycle exit, fusion of myoblasts, and the formation of functional contractile units. Its role extends beyond embryogenesis, contributing to muscle regeneration in adults through satellite cell activation.
Recombinant MYOG protein is produced using expression systems like *E. coli* or mammalian cells, often tagged for purification and detection. Researchers employ it to study muscle differentiation pathways, disease mechanisms (e.g., muscular dystrophy, cachexia), and regenerative therapies. In vitro, it induces stem cell differentiation into myocytes, aiding drug screening for neuromuscular disorders. Challenges include optimizing protein stability and delivery in therapeutic contexts. Current studies explore MYOG’s interplay with signaling pathways (Wnt, Notch) and its potential as a biomarker for muscle health. Despite progress, its transient expression and redundancy with other MRFs complicate therapeutic targeting. Ongoing work focuses on enhancing its specificity and efficacy in gene or protein-based treatments for muscle wasting diseases.
×
